Quarterly report · Q3
4587.TEDINET S100PLL7
Period2022-01-01 → 2022-09-30
Filed2022-11-11
StandardIFRS
ConsolidatedYes
Data checks17 of 17 passed
Key figures · 65
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥11.2bn | 2022-01-01 → 2022-09-30 | Cons. | Revenue IFRS |
| Revenue | ¥6.2bn | 2022-07-01 → 2022-09-30d | Cons. | Revenue IFRS |
| Revenue | ¥9.4bn | 2021-01-01 → 2021-12-31 | Cons. | Revenue IFRS (5-year summary) |
| Revenue | ¥7.8bn | 2021-01-01 → 2021-09-30 | Cons. | Revenue IFRS |
| Revenue | ¥4.9bn | 2021-07-01 → 2021-09-30d | Cons. | Revenue IFRS |
| Operating income | −¥427m | 2022-01-01 → 2022-09-30 | Cons. | Operating profit loss IFRS |
| Operating income | ¥1.2bn | 2022-07-01 → 2022-09-30d | Cons. | Operating profit loss IFRS |
| Operating income | ¥4.0bn | 2021-01-01 → 2021-09-30 | Cons. | Operating profit loss IFRS |
| Operating income | ¥3.6bn | 2021-07-01 → 2021-09-30d | Cons. | Operating profit loss IFRS |
| Profit before tax | −¥369m | 2022-01-01 → 2022-09-30 | Cons. | Profit loss before tax IFRS |
| Profit before tax | ¥1.2bn | 2022-07-01 → 2022-09-30d | Cons. | Profit loss before tax IFRS |
| Profit before tax | ¥3.8bn | 2021-01-01 → 2021-12-31 | Cons. | Profit loss before tax IFRS (5-year summary) |
| Profit before tax | ¥3.8bn | 2021-01-01 → 2021-09-30 | Cons. | Profit loss before tax IFRS |
| Profit before tax | ¥3.5bn | 2021-07-01 → 2021-09-30d | Cons. | Profit loss before tax IFRS |
| Net income (owners) | −¥187m | 2022-01-01 → 2022-09-30 | Cons. | Profit loss attributable to owners of parent IFRS |
| Net income (owners) | ¥946m | 2022-07-01 → 2022-09-30d | Cons. | Profit loss attributable to owners of parent IFRS |
| Net income (owners) | ¥2.6bn | 2021-01-01 → 2021-12-31 | Cons. | Profit loss attributable to owners of parent IFRS (5-year summary) |
| Net income (owners) | ¥2.5bn | 2021-01-01 → 2021-09-30 | Cons. | Profit loss attributable to owners of parent IFRS |
| Net income (owners) | ¥2.5bn | 2021-07-01 → 2021-09-30d | Cons. | Profit loss attributable to owners of parent IFRS |
| Net income | −¥187m | 2022-01-01 → 2022-09-30 | Cons. | Profit loss IFRS |
| Net income | ¥946m | 2022-07-01 → 2022-09-30d | Cons. | Profit loss IFRS |
| Net income | ¥2.6bn | 2021-01-01 → 2021-12-31 | Cons. | Profit loss IFRS (5-year summary) |
| Net income | ¥2.5bn | 2021-01-01 → 2021-09-30 | Cons. | Profit loss IFRS |
| Net income | ¥2.5bn | 2021-07-01 → 2021-09-30d | Cons. | Profit loss IFRS |
| Total assets | ¥51.3bn | at 2022-09-30 | Cons. | Assets IFRS |
| Total assets | ¥27.0bn | at 2021-12-31 | Cons. | Assets IFRS |
| Total assets | ¥28.1bn | at 2021-09-30 | Cons. | Total assets IFRS (5-year summary) |
| Total assets | ¥26.1bn | at 2020-12-31d | Cons. | Assets IFRS |
| Total liabilities | ¥26.8bn | at 2022-09-30 | Cons. | Liabilities IFRS |
| Total liabilities | ¥1.7bn | at 2021-12-31 | Cons. | Liabilities IFRS |
| Total liabilities | ¥4.9bn | at 2020-12-31d | Cons. | Liabilities IFRS |
| Net assets / equity | ¥24.5bn | at 2022-09-30 | Cons. | Equity IFRS |
| Net assets / equity | ¥25.4bn | at 2021-12-31 | Cons. | Equity IFRS |
| Net assets / equity | ¥25.2bn | at 2021-09-30 | Cons. | Equity IFRS |
| Net assets / equity | ¥21.3bn | at 2020-12-31d | Cons. | Equity IFRS |
| Equity (owners) | ¥24.5bn | at 2022-09-30 | Cons. | Equity attributable to owners of parent IFRS |
| Equity (owners) | ¥25.4bn | at 2021-12-31 | Cons. | Equity attributable to owners of parent IFRS |
| Equity (owners) | ¥25.2bn | at 2021-09-30 | Cons. | Equity attributable to owners of parent IFRS (5-year summary) |
| Equity (owners) | ¥21.3bn | at 2020-12-31d | Cons. | Equity attributable to owners of parent IFRS |
| Cash & equivalents | ¥4.6bn | at 2022-09-30 | Cons. | Cash and cash equivalents IFRS |
| Cash & equivalents | ¥11.7bn | at 2021-12-31 | Cons. | Cash and cash equivalents IFRS |
| Cash & equivalents | ¥12.2bn | at 2021-09-30 | Cons. | Cash and cash equivalents IFRS |
| Cash & equivalents | ¥7.1bn | at 2020-12-31d | Cons. | Cash and cash equivalents IFRS |
| Operating cash flow | −¥1.4bn | 2022-01-01 → 2022-09-30 | Cons. | Net cash provided by used in operating activities IFRS |
| Operating cash flow | ¥6.7bn | 2021-01-01 → 2021-12-31 | Cons. | Cash flows from used in operating activities IFRS (5-year summary) |
| Operating cash flow | ¥6.6bn | 2021-01-01 → 2021-09-30 | Cons. | Net cash provided by used in operating activities IFRS |
| Investing cash flow | −¥27.0bn | 2022-01-01 → 2022-09-30 | Cons. | Net cash provided by used in investing activities IFRS |
| Investing cash flow | −¥2.3bn | 2021-01-01 → 2021-12-31 | Cons. | Cash flows from used in investing activities IFRS (5-year summary) |
| Investing cash flow | −¥1.7bn | 2021-01-01 → 2021-09-30 | Cons. | Net cash provided by used in investing activities IFRS |
| Financing cash flow | ¥20.9bn | 2022-01-01 → 2022-09-30 | Cons. | Net cash provided by used in financing activities IFRS |
| Financing cash flow | ¥66m | 2021-01-01 → 2021-12-31 | Cons. | Cash flows from used in financing activities IFRS (5-year summary) |
| Financing cash flow | ¥45m | 2021-01-01 → 2021-09-30 | Cons. | Net cash provided by used in financing activities IFRS |
| EPS (basic) | ¥-1.44 | 2022-01-01 → 2022-09-30 | Cons. | Basic earnings loss per share IFRS |
| EPS (basic) | ¥7.28 | 2022-07-01 → 2022-09-30d | Cons. | Basic earnings loss per share IFRS |
| EPS (basic) | ¥19.96 | 2021-01-01 → 2021-12-31 | Cons. | Basic earnings loss per share IFRS (5-year summary) |
| EPS (basic) | ¥19.25 | 2021-01-01 → 2021-09-30 | Cons. | Basic earnings loss per share IFRS |
| EPS (basic) | ¥19.13 | 2021-07-01 → 2021-09-30d | Cons. | Basic earnings loss per share IFRS |
| EPS (diluted) | ¥-1.44 | 2022-01-01 → 2022-09-30 | Cons. | Diluted earnings loss per share IFRS |
| EPS (diluted) | ¥7.28 | 2022-07-01 → 2022-09-30d | Cons. | Diluted earnings loss per share IFRS |
| EPS (diluted) | ¥19.81 | 2021-01-01 → 2021-12-31 | Cons. | Diluted earnings loss per share IFRS (5-year summary) |
| EPS (diluted) | ¥19.06 | 2021-01-01 → 2021-09-30 | Cons. | Diluted earnings loss per share IFRS |
| EPS (diluted) | ¥19.12 | 2021-07-01 → 2021-09-30d | Cons. | Diluted earnings loss per share IFRS |
| Equity ratio | 47.7% | at 2022-09-30 | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
| Equity ratio | 93.8% | at 2021-12-31 | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
| Equity ratio | 89.4% | at 2021-09-30 | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 13
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | revenue | 2022-01-01 → 2022-09-30 | −¥8m |
| Reconciling Itemsreconciling | revenue intersegment | 2022-01-01 → 2022-09-30 | −¥8m |
| jpcrp040300-q3r_E27486-000Drug Discovery And Development Businessreportable segment | revenue | 2022-01-01 → 2022-09-30 | ¥3.6bn |
| jpcrp040300-q3r_E27486-000Drug Discovery And Development Businessreportable segment | revenue external | 2022-01-01 → 2022-09-30 | ¥3.6bn |
| jpcrp040300-q3r_E27486-000Drug Discovery And Development Businessreportable segment | segment profit | 2022-01-01 → 2022-09-30 | −¥197m |
| jpcrp040300-q3r_E27486-000Radiopharmaceuticals Businessreportable segment | revenue | 2022-01-01 → 2022-09-30 | ¥7.6bn |
| jpcrp040300-q3r_E27486-000Radiopharmaceuticals Businessreportable segment | revenue external | 2022-01-01 → 2022-09-30 | ¥7.6bn |
| jpcrp040300-q3r_E27486-000Radiopharmaceuticals Businessreportable segment | revenue intersegment | 2022-01-01 → 2022-09-30 | ¥8m |
| jpcrp040300-q3r_E27486-000Radiopharmaceuticals Businessreportable segment | segment profit | 2022-01-01 → 2022-09-30 | ¥183m |
| —segment total | revenue | 2022-01-01 → 2022-09-30 | ¥11.2bn |
| —segment total | revenue external | 2022-01-01 → 2022-09-30 | ¥11.2bn |
| —segment total | revenue intersegment | 2022-01-01 → 2022-09-30 | ¥8m |
| —segment total | segment profit | 2022-01-01 → 2022-09-30 | −¥14m |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 629
| Item | Context | Value | Unit |
|---|---|---|---|
| Cash flows from used in financing activities IFRS (5-year summary) | Prior1YTDDuration | 44583000 | JPY |
| Cash flows from used in financing activities IFRS (5-year summary) | CurrentYTDDuration | 20925538000 | JPY |
| Cash flows from used in financing activities IFRS (5-year summary) | Prior1YearDuration | 66067000 | JPY |
| Cash and cash equivalents IFRS (5-year summary) | Prior1QuarterInstant | 12236604000 | JPY |
| Cash and cash equivalents IFRS (5-year summary) | CurrentQuarterInstant | 4562743000 | JPY |
| Cash and cash equivalents IFRS (5-year summary) | Prior1YearInstant | 11746529000 | JPY |
| Number of issued shares as of fiscal year end issued shares total number of shares etc | FilingDateInstant_OrdinaryShareMember | 130010400 | |
| Number of issued shares as of filing date issued shares total number of shares etc | FilingDateInstant_OrdinaryShareMember | 130010400 | |
| Number of issued shares as of fiscal year end issued shares total number of shares etc | FilingDateInstant | 130010400 | |
| Number of issued shares as of filing date issued shares total number of shares etc | FilingDateInstant | 130010400 | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_SharesWithNoVotingRightsMember | － | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_SharesWithRestrictedVotingRightsTreasurySharesEtcMember | － | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_SharesWithRestrictedVotingRightsOtherMember | － | |
| Number of voting rights issued shares voting rights | CurrentQuarterInstant_SharesWithRestrictedVotingRightsOtherMember | － | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_OrdinarySharesTreasurySharesSharesWithFullVotingRightsTreasurySharesEtcMember | 200 | |
| Number of voting rights issued shares voting rights | CurrentQuarterInstant_OrdinarySharesSharesWithFullVotingRightsOtherMember | 1299763 | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_OrdinarySharesSharesWithFullVotingRightsOtherMember | 129976300 | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_OrdinarySharesSharesLessThanOneUnitMember | 33900 | |
| Number of shares issued shares voting rights | CurrentQuarterInstant | 130010400 | |
| Number of voting rights issued shares voting rights | CurrentQuarterInstant | 1299763 | |
| Number of shares held in own name treasury shares etc | CurrentQuarterInstant_Row1Member | 200 | |
| Number of shares held in others names treasury shares etc | CurrentQuarterInstant_Row1Member | － | |
| Total number of shares held treasury shares etc | CurrentQuarterInstant_Row1Member | 200 | |
| Shareholding ratio treasury shares etc | CurrentQuarterInstant_Row1Member | 0.0000 | |
| Number of shares held in own name treasury shares etc | CurrentQuarterInstant | 200 | |
| Number of shares held in others names treasury shares etc | CurrentQuarterInstant | － | |
| Total number of shares held treasury shares etc | CurrentQuarterInstant | 200 | |
| Shareholding ratio treasury shares etc | CurrentQuarterInstant | 0.0000 | |
| Cash and cash equivalents IFRS | Prior2YearInstant | 7149358000 | JPY |
| Cash and cash equivalents IFRS | Prior1YearInstant | 11746529000 | JPY |
| Cash and cash equivalents IFRS | CurrentQuarterInstant | 4562743000 | JPY |
| Trade and other receivables ca IFRS | Prior2YearInstant | 7530584000 | JPY |
| Trade and other receivables ca IFRS | Prior1YearInstant | 811096000 | JPY |
| Trade and other receivables ca IFRS | CurrentQuarterInstant | 6291777000 | JPY |
| Other financial assets ca IFRS | Prior2YearInstant | 6241000 | JPY |
| Other financial assets ca IFRS | Prior1YearInstant | 69047000 | JPY |
| Other financial assets ca IFRS | CurrentQuarterInstant | 420340000 | JPY |
| Inventories ca IFRS | Prior2YearInstant | 585981000 | JPY |
| Inventories ca IFRS | Prior1YearInstant | 925138000 | JPY |
| Inventories ca IFRS | CurrentQuarterInstant | 2386626000 | JPY |
| Income taxes receivable ca IFRS | Prior2YearInstant | － | JPY |
| Income taxes receivable ca IFRS | Prior1YearInstant | 10415000 | JPY |
| Income taxes receivable ca IFRS | CurrentQuarterInstant | 476618000 | JPY |
| Other current assets ca IFRS | Prior2YearInstant | 369353000 | JPY |
| Other current assets ca IFRS | Prior1YearInstant | 274197000 | JPY |
| Other current assets ca IFRS | CurrentQuarterInstant | 645893000 | JPY |
| Current assets IFRS | Prior2YearInstant | 15641519000 | JPY |
| Current assets IFRS | Prior1YearInstant | 13836425000 | JPY |
| Current assets IFRS | CurrentQuarterInstant | 14784001000 | JPY |
| Property plant and equipment IFRS | Prior2YearInstant | 5766856000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 17 of 17 passed
| balance sheet identity | pass |
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |